Clinical management of autoimmune hepatitis

Clinical management of autoimmune hepatitis

Autoimmune hepatitis is a rare and chronic liver disease that is characterised by increased serum transaminases and immunoglobulin G, inflammatory liver histology and presence of circulating autoantibodies. An autoimmune hepatitis diagnosis justifies life-long treatment in most patients in order to...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Simon Pape, Christoph Schramm, Tom J.G. Gevers
Format:	Revisão
Jezik:	angleščina
Izdano:	2019
Online dostop:	https://doi.org/10.1177/2050640619872408 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1177/2050640619872408
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Clinical management of autoimmune hepatitis
od: Pape, Simon, et al.
Izdano: (2019)

Health-related quality of life in autoimmune hepatitis
od: Snijders, Romée JALM, et al.
Izdano: (2021)

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis
od: Simon Pape, et al.
Izdano: (2019)

Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
od: Simon Pape, et al.
Izdano: (2019)

Evaluation of hepatic cystic lesions
od: Lantinga, Marten A, et al.
Izdano: (2013)

Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life
od: Schramm, Christoph
Izdano: (2019)

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
od: Pape, Simon, et al.
Izdano: (2020)

Drug induced liver injury and its relationship to autoimmune hepatitis
od: Christina Weiler‐Normann, et al.
Izdano: (2011)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
od: Nwe Ni Than, et al.
Izdano: (2019)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
od: Than, Nwe Ni, et al.
Izdano: (2019)

Clinical features and management of autoimmune hepatitis
od: Krawitt, Edward L
Izdano: (2008)

Diagnosis and management of autoimmune hepatitis
od: Michael P. Manns, et al.
Izdano: (2010)

Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
od: Simon Pape, et al.
Izdano: (2022)

Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management
od: Simon C. Ling
Izdano: (2015)

Expert clinical management of autoimmune hepatitis in the real world
od: Rodrigo Liberal, et al.
Izdano: (2016)

Diagnosis and management of autoimmune hepatitis
od: Luigi Muratori, et al.
Izdano: (2023)

Autoimmune hepatitis and complexities in management
od: Janmohamed, Ashnila, et al.
Izdano: (2019)

Management of Autoimmune Hepatitis in Pregnant Women
od: Peters, Marion G.
Izdano: (2017)

Management and outcome of pregnancy in autoimmune hepatitis
od: Michael A. Heneghan, et al.
Izdano: (2001)

Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
od: Marcial Sebode, et al.
Izdano: (2018)

Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
od: Sebode, Marcial, et al.
Izdano: (2018)

Challenges in the diagnosis and management of autoimmune hepatitis
od: Czaja, Albert J
Izdano: (2013)

Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
od: Wijnands, Titus FM, et al.
Izdano: (2015)

Management and outcome of pregnancy in autoimmune hepatitis
od: Heneghan, M, et al.
Izdano: (2001)

A disease-specific decline of the relative abundance of<i>Bifidobacterium</i>in patients with autoimmune hepatitis
od: Timur Liwinski, et al.
Izdano: (2020)

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
od: Rüther, Darius Ferenc, et al.
Izdano: (2022)

Simplified criteria for the diagnosis of autoimmune hepatitis
od: Elke Hennes, et al.
Izdano: (2008)

Recent updates on the management of autoimmune hepatitis
od: Atsumasa Komori
Izdano: (2020)

Management of patients with difficult autoimmune hepatitis
od: Parker, Richard, et al.
Izdano: (2012)

Management of Difficult Cases of Autoimmune Hepatitis
od: Lammert, Craig, et al.
Izdano: (2016)

Recent updates on the management of autoimmune hepatitis
od: Komori, Atsumasa
Izdano: (2021)

Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER)
od: Codoni, Greta, et al.
Izdano: (2022)

Tolerance and autoimmunity in the liver
od: Schramm, Christoph, et al.
Izdano: (2022)

Diagnosis and Management of the Overlap Syndromes of Autoimmune Hepatitis
od: Albert J. Czaja
Izdano: (2013)

Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
od: Pape, Simon, et al.
Izdano: (2020)

Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
od: Albert J. Czaja, et al.
Izdano: (2010)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
od: Laschtowitz, Alena, et al.
Izdano: (2021)

Diagnosis and management of the overlap syndromes of autoimmune hepatitis
od: Czaja, Albert J
Izdano: (2013)

Autoimmune hepatitis: Clinical challenges
od: Michael P. Manns, et al.
Izdano: (2001)

Ultrasound findings in autoimmune hepatitis
od: Dong, Yi, et al.
Izdano: (2018)